Shukui Qin, MD
NanJing PLA 81 Hospital
3
3
1
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Yan Sun, MD
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Shared therapeutic areas:
Worked with same sponsors:
Wanguang Zhang, M.D.
Tongji Hospital
Shared therapeutic areas:
Worked with same sponsors:
Tsang-Wu Liu
Taiwan Cooperative Oncology Group, NHRI
Shared therapeutic areas:
Sirish Kishore, MD
VA Palo Alto Health Care System
Shared therapeutic areas:
Shuhang Wang
NCC, CICAMS
Shared therapeutic areas:
Worked with same sponsors:
Dejan Reljic, Dr.
University Erlangen Nuremberg Medical School
Shared therapeutic areas:
yan hai Liu
The Second Affiliated Hospital of Shandong First Medical University
Shared therapeutic areas:
Gao-jun Teng, M.D
Zhongda hospital, Southeast university, Nanjing, China
Shared therapeutic areas:
Yoon Jun Kim, MD, PhD
Seoul National University Hospital
Shared therapeutic areas:
Mark Jones, MD
Incyte Corporation
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
The Phase III Study of Icaritin Versus Sorafenib in PD-L1 Positive Advanced Hepatocellular Carcinoma Subjects
The Phase II Study of Icaritin in Patients With Advanced Hepatocellular Carcinoma
A Multicenter Real World Study of Kanglaite for Cancer Cachexia
All 3 trials loaded